Previous 10 | Next 10 |
Image source: The Motley Fool. Zynex, inc (NASDAQ: ZYXI) Q3 2021 Earnings Call Nov 2, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, inc (ZYXI) Q3 2021 Earnings Call Transcript
Zynex (NASDAQ:ZYXI): Q3 GAAP EPS of $0.17 beats by $0.05. Revenue of $34.8M (+74.0% Y/Y) misses by $0.64M. Shares +2%. Press Release For further details see: Zynex EPS beats by $0.05, misses on revenue
Zynex Announces 2021 Third Quarter Earnings PR Newswire ENGLEWOOD, Colo. , Nov. 2, 2021 /PRNewswire/ -- 2021 Third Quarter Revenue increased 74% year over year to $34.8 million Orders increased 70% Record net income...
ADC, AFG, DADA, AIZ, AKAM, AMCR, AMED, AMGN, ANDE, APPS, AQST, ATVI, AWK, AYX, BFAM, BGFV, BKH, BTG, BXC, CASA, CDK, CDLX, CERS, CGBD, CHCT, CHK, CLW, COUR, CRK, [CSLT]], CVGI, CZR, DCP, DCPH, DENN, DHT, DOX, DRRX, [DVN]], EARN, EGHT, EIX, EKSO, ELVT, ENLC, EXAS, EXEL, FMC, FNF, FRG, GAIN, GN...
Zynex Schedules 2021 Third Quarter Earnings Call PR Newswire ENGLEWOOD, Colo., Oct. 25, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pai...
Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate PR Newswire ENGLEWOOD, Colo. , Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-in...
Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference PR Newswire ENGLEWOOD, Colo. , Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing ...
Zynex faces at least 12 contentious issues that reveal troubling fundamentals. The business model is not sustainable for the long term. The shares are grossly overvalued based on DCF, Discount EPS, and Reverse DCF and Reverse EPS valuation models. Until ethical concerns and th...
Public health officers have been focused on Covid-19 for the last 18 months and all other public health issues have taken a back seat to Covid-19 response efforts. Opioid overdoses have increased during the pandemic. Zynex has seen rapid growth in revenues and earnings but the sto...
Gainers: ERYTECH Pharma (NASDAQ:ERYP) +64%. Allied Healthcare Products (NASDAQ:AHPI) +49%. iFresh (NASDAQ:IFMK) +35%. Marin Software Incorporated (NASDAQ:MRIN) +29%. Atlassian Corporation (NASDAQ:TEAM) +24%. Xiaobai Maimai (NASDAQ:HX) +18%. First High-School Education (NYSE:FHS) +16%. Bridgel...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...